share_log

RBC Capital Initiates Coverage On Sophia Genetics With Outperform Rating, Announces Price Target of $8

RBC Capital Initiates Coverage On Sophia Genetics With Outperform Rating, Announces Price Target of $8

加拿大皇家银行资本以跑赢大盘的评级启动对索菲亚遗传学的报道,宣布目标股价为8美元
Benzinga ·  2023/11/29 05:53

RBC Capital analyst Conor McNamara initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Outperform rating and announces Price Target of $8.

加拿大皇家银行资本分析师康纳·麦克纳马拉以跑赢大盘的评级开始对索菲亚遗传学(纳斯达克股票代码:SOPH)进行报道,并宣布目标股价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发